Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
11.41
-0.76 (-6.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
Benitec Biopharma Employees
Benitec Biopharma had 16 employees as of June 30, 2024. The number of employees decreased by 2 or -11.11% compared to the previous year.
Employees
16
Change (1Y)
-2
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,303,500
Market Cap
264.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
TruBridge | 3,219 |
Zynex | 1,100 |
Lifecore Biomedical | 524 |
AC Immune | 161 |
Atea Pharmaceuticals | 75 |
Chimerix | 72 |
Artiva Biotherapeutics | 43 |
Renovaro | 25 |
BNTC News
- 25 days ago - Benitec Biopharma to Participate in Upcoming Investor Conferences in December - GlobeNewsWire
- 5 weeks ago - Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 6 weeks ago - Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference - GlobeNewsWire
- 2 months ago - Benitec Biopharma: OPMD Program Continues To Advance With Catalysts - Seeking Alpha
- 2 months ago - Benitec Biopharma Announces Updated Investor Webcast Information - GlobeNewsWire
- 2 months ago - Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society - GlobeNewsWire
- 3 months ago - Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update - GlobeNewsWire
- 3 months ago - Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society - GlobeNewsWire